"Die Schön Klinik Hamburg Eilbek ist als Akademisches Lehrkrankenhaus der Universität Hamburg mit mehr als 800 Betten und rund 1.600 Mitarbeitenden eines der größten Krankenhäuser in Hamburg. Wir bieten hochqualifizierte medizinische Spezialleistungen und sind gleichzeitig im Notfall rund um die Uhr für Sie da."

During the past decade, Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie" are "Rheumatoid Arthritis" (3 trials), "Arthritis, Rheumatoid" (1 trials) and "Spondylitis, Ankylosing" (1 trials). Many other conditions were trialed in "Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie" in a lesser frequency.

Most popular intervention types in "Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tocilizumab" (2 trials), "Background NSAID" (1 trials), "CP-690,550" (1 trials), "Disease-modifying antirheumatic drug" (1 trials) and "Etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schön Klinik Hamburg-Eilbek Klinik für Rheumatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".